A share price of Exagen Inc [XGN] is currently trading at $7.18, up 2.57%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The XGN shares have gain 2.57% over the last week, with a monthly amount drifted -3.49%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Exagen Inc [NASDAQ: XGN] stock has seen the most recent analyst activity on August 05, 2022, when KeyBanc Capital Markets downgraded its rating to a Sector Weight. On April 15, 2021, Canaccord Genuity initiated with a Buy rating and assigned a price target of $25 on the stock. KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and suggested a price target of $32 on November 10, 2020. BTIG Research initiated its recommendation with a Buy and recommended $18 as its price target on October 08, 2020. In a note dated October 14, 2019, William Blair initiated an Outperform rating.
Exagen Inc experienced fluctuations in its stock price throughout the past year between $1.78 and $7.95. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. Exagen Inc [NASDAQ: XGN] shares were valued at $7.18 at the most recent close of the market. An investor can expect a potential drop of -30.36% based on the average XGN price forecast.
Analyzing the XGN fundamentals
Trailing Twelve Months sales for Exagen Inc [NASDAQ:XGN] were 56.72M which represents 7.51% growth. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at -0.25%, Pretax Profit Margin comes in at -0.27%, and Net Profit Margin reading is -0.27%. To continue investigating profitability, this company’s Return on Assets is posted at -0.38, Equity is -1.34 and Total Capital is -0.53. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.79.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Exagen Inc [NASDAQ:XGN] is 2.32. Further, the Quick Ratio stands at 1.98, while the Cash Ratio is 0.8. Considering the valuation of this stock, the price to sales ratio is 2.77, the price to book ratio is 20.13.
Transactions by insiders
Recent insider trading involved NMSIC Co-Investment Fund, L.P., 10% Owner, that happened on Mar 25 ’25 when 0.35 million shares were sold. 10% Owner, NMSIC Co-Investment Fund, L.P. completed a deal on Nov 20 ’24 to sell 0.2 million shares. Meanwhile, Chief Financial Officer Black Jeffrey G. bought 22298.0 shares on Nov 15 ’24.
